Latest News

In March 2026, Synchrony Financial announced a partnership with Figo Pet Insurance that lets pet owners use CareCredit to pay upfront vet bills and receive approved insurance reimbursements directly as credits to their CareCredit accounts. This integration expands CareCredit’s pet insurance reimbursement ecosystem to more than 1.20 billion insured policyholders across Figo, Pets Best, and Pumpkin, simplifying veterinary payments for customers and clinics. Next, we’ll examine how this...

In the first quarter of 2026, Hamamatsu Photonics K.K. completed a board-approved buyback of 7,662,800 shares for ¥13,010.92 million, while Sakura Finetek and Hamamatsu announced an alliance to create a seamless workflow from tissue preparation to digital pathology imaging. Together, these moves highlight Hamamatsu’s focus on integrating its imaging technology into clinical diagnostics workflows while actively returning capital to shareholders through repurchases. We’ll now examine how...

AirSculpt Technologies (AIRS) has wrapped up FY 2025 with Q4 revenue of US$33.4 million and net income of US$1.3 million, translating to basic EPS of US$0.02. Over the trailing twelve months, the company reported revenue of US$151.8 million and a net loss of US$11.7 million, or a basic EPS loss of US$0.19. During FY 2025, quarterly revenue ranged from US$33.4 million to US$44.0 million, while basic EPS moved between a loss of US$0.15 and a small profit of US$0.02. This puts the latest quarter...

In late March 2026, IonQ’s shares weakened as heightened geopolitical tensions in the Middle East, particularly the conflict with Iran, weighed on broader equity markets and dampened risk appetite. At the same time, IonQ’s memorandum of understanding with South Korea’s KISTI to integrate its quantum systems with local high-performance computing highlights the company’s growing role in global quantum infrastructure and workforce development. Against this backdrop, we’ll explore how...

Tarsus Pharmaceuticals (TARS) has drawn fresh attention after dosing the first participant in its Phase 2 Calliope trial of TP-05, an oral candidate aimed at preventing Lyme disease by killing infected ticks. See our latest analysis for Tarsus Pharmaceuticals. The recent TP-05 progress and TP-03 milestone in China come as the share price sits at US$70.22, with a 7 day share price return of 4.9% but a 90 day share price return showing a 14.2% decline. The 1 year total shareholder return of...

If you are wondering whether Legend Biotech's share price reflects its underlying value, this article breaks down what the current market price may be implying about the company. The stock closed at US$19.05, with returns of 8.2% over the last week and 3.3% over the last month. The 1 year return stands at a 42.7% decline and the 3 year return at a 60.5% decline. Recent coverage around Legend Biotech has focused on its position in the biotech space and how investors are reassessing risk and...

Ameresco (NYSE:AMRC) has introduced a dual Co President structure alongside the appointment of a new Chief Operating Officer. The leadership changes mark a major organizational restructure aimed at supporting growth and project execution across the business. Ameresco focuses on energy efficiency, renewable energy projects, and related services, an area that depends heavily on disciplined project management and long term contracts. As the company works across government, commercial, and...

If you are wondering whether Millrose Properties at US$28.51 still offers value after its recent run, this article will help you frame that question clearly. The stock has seen a 3.1% decline over the last 7 days and an 8.0% decline over the last 30 days, while still showing a 17.4% return over the last year and a 4.4% decline year to date. Recent news flow around Millrose Properties has focused on its position within the real estate sector and how sentiment toward property related names has...

If you are wondering whether ONEOK is priced fairly or if the current share price leaves some value on the table, this breakdown will help you frame that question in a structured way. With the stock at US$87.36, recent returns have been mixed, including a 5.2% decline over the last 7 days, a 1.4% return over 30 days, 17.5% year to date, and an 8.1% decline over the past year, set against a 54.9% and 126.6% return over 3 and 5 years respectively. Recent coverage has largely focused on ONEOK's...

Why Bank of New York Mellon Corporation (BK) Is On Investors’ Radar Bank of New York Mellon Corporation (BK) has attracted attention after a solid run, with total return figures over the past year and past 3 years prompting fresh interest in how the stock is currently priced. See our latest analysis for Bank of New York Mellon. With the share price at $120.97 and a 1-day share price return of 1.97%, recent gains add to a steady upward trend. The 1-year total shareholder return of 46.66% and...

Wondering whether Mercedes-Benz Group is trading at an attractive price or carrying hidden risks at current levels? This article focuses squarely on what the numbers say about its valuation. The stock recently closed at €52.88, with a 1.1% return over 7 days, a 6.6% decline over 30 days, a 14.6% decline year to date, and a 6.5% return over the last year, which may prompt you to reassess both upside potential and downside risk. Alongside these moves, investors have been reacting to ongoing...

RWE (XTRA:RWE) has agreed to sell its Swedish wind activities to Aneo as part of an ongoing portfolio reshaping in renewables. The transaction involves RWE exiting its wind business in Sweden to sharpen its focus on core markets. The move is presented as a step in refining the group’s renewables growth plan and simplifying its operations. RWE is a large European utility group with a focus on renewable power, including wind, solar and other clean energy assets. By divesting Swedish wind...

Recent performance context for Paychex stock Paychex (PAYX) has seen its share price under pressure recently, with negative returns over the past week, month and past 3 months, and a 39.26% decline over the past year. See our latest analysis for Paychex. At a share price of US$90.91, the stock’s recent slide is consistent with its 18.96% 3 month share price decline and 39.26% 1 year total shareholder return decline. This suggests momentum has been fading as investors reassess growth prospects...

In late March 2026, Royal Gold, Inc. issued 2026 guidance calling for higher gold, silver, and copper sales volumes than 2025, outlined expectations for minor contributions from other metals based on assumed reference prices, and indicated that sales would be slightly weighted toward the second half of the year. The company also repaid US$125 million on its revolving credit facility, published a detailed 2025/2026 Asset Handbook, and introduced a new five-year outlook that together give...

On March 24, 2026, Judo Capital Holdings Limited appointed David Stephen, a former Group Chief Risk Officer at several major banks, as an Independent Non-Executive Director, bringing more than 35 years of banking, risk management and compliance experience to its board. His background in driving risk transformation and overseeing organizations in complex, highly regulated settings adds extra depth to Judo’s governance and risk oversight framework. Next, we’ll consider how adding a seasoned...

Q2 Holdings (QTWO) has partnered with Stablecore to give banks and credit unions access to stablecoins, tokenized deposits, and other digital asset products through its existing digital banking platform. See our latest analysis for Q2 Holdings. The Stablecore partnership comes as Q2 Holdings' short-term momentum has softened, with a 30-day share price return showing a 5.65% decline and a 90-day share price return showing a 34.31% decline. The three-year total shareholder return of 105.64%...

Woodside Energy Group (ASX:WDS) has taken operational control of the Beaumont New Ammonia facility in southeast Texas, adding a large scale US ammonia producer and exporter to its portfolio. See our latest analysis for Woodside Energy Group. The Beaumont ammonia news lands at a time when momentum in the stock has been building, with a 30 day share price return of 16.04%, a 90 day share price return of 48.75% and a 1 year total shareholder return of 60.66%. This suggests that investors are...

Badger Meter (NYSE:BMI) expanded its share repurchase authorization by $75 million, signaling a larger capital return program to shareholders. The move comes alongside an analyst upgrade and fresh insider share purchases, pointing to increased confidence from both the board and management. Management also highlighted continued growth in the SmartCover business, which is becoming a more visible contributor within the portfolio. Badger Meter, trading at $154.21, has had mixed share...

Mawer New Canada Fund’s latest report put Hammond Power Solutions (TSX:HPS.A) in focus, after the fund made it its largest new holding shortly after Hammond’s full year 2025 earnings release. See our latest analysis for Hammond Power Solutions. Hammond Power Solutions’ recent 2.6% 1 day share price gain comes after a 7.6% 7 day and 9.8% 30 day share price pullback. However, its 12.8% 90 day share price return and very large 5 year total shareholder return suggest momentum has been strong over...

In late March 2026, Sterling Infrastructure drew attention after CEO Joseph Cutillo sold about US$22.7 million of shares, sparking questions about insider confidence and governance. This insider activity stands in contrast to previously strong bullish analyst sentiment, highlighting how management actions can challenge even well-supported investment cases. Next, we examine how the CEO’s sizeable insider sale may affect Sterling Infrastructure’s investment narrative and perceived risk...

International Flavors & Fragrances recently announced that Food Standards Australia New Zealand approved a heart health claim for isolated soy protein, allowing foods in Australia and New Zealand delivering 20–25 grams daily to promote benefits for blood cholesterol as part of a balanced diet. This regulatory milestone expands the scope for IFF’s SOLAE SUPRO soy protein portfolio in plant-based and functional foods, giving brands new ways to link clinically supported heart health benefits...

HBM equipment order puts Besi’s hybrid bonding role in focus BE Semiconductor Industries (ENXTAM:BESI) just secured its first mass production hybrid bonding equipment order from SK hynix, developed together with Applied Materials, tying the company directly to next generation high bandwidth memory deployment. See our latest analysis for BE Semiconductor Industries. Investors appear to be reacting positively to Besi’s HBM exposure, with the 1-day share price return of 4.81% and 90-day share...

In March 2026, Torex Gold Resources Inc. reported its 2025 year-end mineral reserves and resources, highlighting extended reserve life at ELG Underground, an inaugural inferred resource at Media Luna West, and the addition of substantial resources from the Los Reyes project acquired via Prime Mining. An important insight is that while Morelos reserves declined slightly after depletion, inferred resources and total resource inventory grew meaningfully, aided by Los Reyes and revised reporting...

If you are wondering whether Lloyds Banking Group at around £0.98 is still good value after its recent run, the starting point is understanding what the current share price actually reflects about the business. The stock has returned 2.8% over the last 7 days, while the 30 day and year to date returns of 2.2% decline and 1.6% decline sit alongside a 41.6% return over 1 year, 135.8% over 3 years and 184.0% over 5 years. Recent coverage has focused on Lloyds as one of the major UK banks...